Literature DB >> 15033571

Functional domains of the influenza A virus PB2 protein: identification of NP- and PB1-binding sites.

Emma Poole1, Debra Elton, Liz Medcalf, Paul Digard.   

Abstract

Influenza virus genomic RNA segments are packaged into ribonucleoprotein (RNP) structures by the PB1, PB2, and PA subunits of an RNA polymerase and a single-strand RNA-binding nucleoprotein (NP). Assembly and function of these ribonucleoproteins depend on a complex set of protein-protein and protein-RNA interactions. Here, we identify new functional domains of PB2. We show that PB2 contains two regions that bind NP and also identify a novel PB1 binding site. The regions of PB2 responsible for binding NP and PB1 show considerable overlap, and binding of NP to the PB2 fragments could be outcompeted by PB1. The binding domains of PB2 acted as trans-dominant inhibitors of viral gene expression, and consistent with the in vitro binding data, their inhibitory activity depended on the concentration of wild-type PB2, NP, and PB1. This provides evidence for functionally significant and potentially regulatory interactions between PB2 and NP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033571     DOI: 10.1016/j.virol.2003.12.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  68 in total

Review 1.  Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms.

Authors:  Stéphane Boivin; Stephen Cusack; Rob W H Ruigrok; Darren J Hart
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  Targeting of the influenza A virus polymerase PB1-PB2 interface indicates strain-specific assembly differences.

Authors:  Peter Reuther; Benjamin Mänz; Linda Brunotte; Martin Schwemmle; Kerstin Wunderlich
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

3.  Sequence in the influenza A virus nucleoprotein required for viral polymerase binding and RNA synthesis.

Authors:  Jesper K Marklund; Qiaozhen Ye; Jinhui Dong; Yizhi Jane Tao; Robert M Krug
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

4.  NP, PB1, and PB2 viral genes contribute to altered replication of H5N1 avian influenza viruses in chickens.

Authors:  Jamie L Wasilenko; Chang Won Lee; Luciana Sarmento; Erica Spackman; Darrell R Kapczynski; David L Suarez; Mary J Pantin-Jackwood
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

5.  Peptide-mediated interference with influenza A virus polymerase.

Authors:  Alexander Ghanem; Daniel Mayer; Geoffrey Chase; Werner Tegge; Ronald Frank; Georg Kochs; Adolfo García-Sastre; Martin Schwemmle
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

6.  An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase.

Authors:  Andrew Mehle; Jennifer A Doudna
Journal:  Cell Host Microbe       Date:  2008-08-14       Impact factor: 21.023

7.  Compatibility among polymerase subunit proteins is a restricting factor in reassortment between equine H7N7 and human H3N2 influenza viruses.

Authors:  Chengjun Li; Masato Hatta; Shinji Watanabe; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

8.  Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.

Authors:  Nathalie Lejal; Bogdan Tarus; Edwige Bouguyon; Sylvie Chenavas; Nicolas Bertho; Bernard Delmas; Rob W H Ruigrok; Carmelo Di Primo; Anny Slama-Schwok
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

9.  Identification of a Novel Viral Protein Expressed from the PB2 Segment of Influenza A Virus.

Authors:  Seiya Yamayoshi; Mariko Watanabe; Hideo Goto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

Review 10.  Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier.

Authors:  Benjamin Mänz; Martin Schwemmle; Linda Brunotte
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.